Pre-transplant End-stage Renal Disease-related Immune Risk Profile in Kidney Transplant Recipients Predicts Post-transplant Infections
Overview
Infectious Diseases
Authors
Affiliations
Background: End-stage renal disease (ESRD) is associated with premature aging of the T-cell system. Nevertheless, the clinical significance of pre-transplant ESRD-related immune senescence is unknown.
Methods: We studied whether immune risk phenotype (IRP), a typical feature of immune senescence, may affect post-transplant infectious complications. A total of 486 patients were prospectively studied during the first year post transplant. IRP was defined as positive cytomegalovirus serology with at least 1 of the following criteria: CD4/CD8 ratio <1 and/or CD8 T-cell count >90th percentile.
Results: We found that 47 patients (9.7%) had pre-transplant IRP. IRP+ patients did not differ from IRP- patients for any clinical characteristics, but exhibited more pronounced immune senescence. Both opportunistic infections (43% vs. 6%, P < 0.001) and severe bacterial infection (SBI) (40% vs. 25%, P = 0.028) were more frequent in IRP(+) patients. In multivariate analysis, IRP was predictive of both opportunistic infection (hazard ratio [HR] 2.97 [95% confidence interval {CI} 1.53-5.76], P = 0.001), and SBI (HR 2.33 [95% CI 1.34-3.92], P = 0.008). Acute rejection rates were numerically much lower in IRP+ patients. A total of 418 patients (86%) had biological evaluation 1 year post transplant. Among 41 IRP+ patients, 35 (85%) remained IRP+ 1 year post transplant.
Conclusion: Pre-transplant IRP is associated with an increased risk of post-transplant infection.
Tharmaraj D, Mulley W, Dendle C Front Immunol. 2024; 15:1490472.
PMID: 39660122 PMC: 11628869. DOI: 10.3389/fimmu.2024.1490472.
Fouza A, Fylaktou A, Tagkouta A, Daoudaki M, Vagiotas L, Kasimatis E J Clin Med. 2024; 13(21).
PMID: 39518592 PMC: 11547170. DOI: 10.3390/jcm13216454.
Ryan R, Bentall A, Issa N, Dean P, Smith B, Stegall M Transplant Direct. 2024; 10(10):e1698.
PMID: 39328252 PMC: 11427033. DOI: 10.1097/TXD.0000000000001698.
Gaiffe E, Colladant M, Desmaret M, Bamoulid J, Leroux F, Laheurte C Front Immunol. 2023; 14:1192440.
PMID: 37497224 PMC: 10367005. DOI: 10.3389/fimmu.2023.1192440.
Schneider S, Carlson A, Sirandas B, Clark B, Truax C Transpl Infect Dis. 2022; 24(6):e13973.
PMID: 36263508 PMC: 9874435. DOI: 10.1111/tid.13973.